BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21653951)

  • 1. During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved.
    Ozawa S; Stack ML; Bishai DM; Mirelman A; Friberg IK; Niessen L; Walker DG; Levine OS
    Health Aff (Millwood); 2011 Jun; 30(6):1010-20. PubMed ID: 21653951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity.
    Stack ML; Ozawa S; Bishai DM; Mirelman A; Tam Y; Niessen L; Walker DG; Levine OS
    Health Aff (Millwood); 2011 Jun; 30(6):1021-8. PubMed ID: 21653952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
    Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
    Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why The Decade Of Vaccines?
    Health Aff (Millwood); 2016 Feb; 35(2):188-9. PubMed ID: 26858368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccines and developing countries].
    Bjune G
    Tidsskr Nor Laegeforen; 1991 May; 111(12):1496-9. PubMed ID: 2042182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the world afford to save the lives of 6 million children each year?
    Bryce J; Black RE; Walker N; Bhutta ZA; Lawn JE; Steketee RW
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2193-200. PubMed ID: 15978927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerating the benefits of the 'decade of vaccines'.
    Light DW
    Health Aff (Millwood); 2011 Oct; 30(10):2026; author's reply 2026-7. PubMed ID: 21976349
    [No Abstract]   [Full Text] [Related]  

  • 8. A handful of 'antipoverty' vaccines exist for neglected diseases, but the world's poorest billion people need more.
    Hotez P
    Health Aff (Millwood); 2011 Jun; 30(6):1080-7. PubMed ID: 21653960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introducing new vaccines into developing countries: obstacles, opportunities and complexities.
    Clemens J; Jodar L
    Nat Med; 2005 Apr; 11(4 Suppl):S12-5. PubMed ID: 15812482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, content and financing of an essential national package of health services.
    Bobadilla JL; Cowley P; Musgrove P; Saxenian H
    Bull World Health Organ; 1994; 72(4):653-62. PubMed ID: 7923544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    Ahonkhai V; Martins SF; Portet A; Lumpkin M; Hartman D
    PLoS One; 2016; 11(11):e0166515. PubMed ID: 27851831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.
    Ozawa S; Clark S; Portnoy A; Grewal S; Brenzel L; Walker DG
    Health Aff (Millwood); 2016 Feb; 35(2):199-207. PubMed ID: 26858370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines, global health and social equity.
    Levine MM; Robins-Browne R
    Immunol Cell Biol; 2009; 87(4):274-8. PubMed ID: 19308074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines as a global imperative--a business perspective.
    Stéphenne J
    Health Aff (Millwood); 2011 Jun; 30(6):1042-8. PubMed ID: 21653955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine progress reveals resource gaps in developing countries.
    Burki TK
    Lancet Infect Dis; 2011 Mar; 11(3):165-6. PubMed ID: 21491698
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunizations climb, then falter.
    Kane H
    World Watch; 1994; 7(3):33-4. PubMed ID: 12287702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human development?
    Philippine Legislators' Committee on Population and Development Foundation
    People Count; 1993 Feb; 3(1):1-4. PubMed ID: 12179224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020.
    Gandhi G; Lydon P; Cornejo S; Brenzel L; Wrobel S; Chang H
    Vaccine; 2013 Apr; 31 Suppl 2():B137-48. PubMed ID: 23598475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.